AGM
NEO icon

Alpine Global Management’s NeoGenomics NEO Stock Holding History

Alpine Global Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,071
Closed -$112K – 318
2022
Q4 		$112K Buy
+12,071
New +$113K 0.04% 227
2021
Q2 		– Sell
-5,419
Closed -$261K – 345
2021
Q1 		$261K Buy
+5,419
New +$282K 0.03% 218

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpine Global Management's NEO Position: Q1 2023 in Review

Alpine Global Management sold out of NeoGenomics (NEO) in Q1 2023, closing a stake of 12,071 shares — an estimated $112K sold.

Alpine Global Management first reported a position in NEO in Q1 2021 and held it in 2 quarters. The position peaked at $261K in Q1 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2023.

  • Alpine Global Management reported no remaining NeoGenomics position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 12,071 NeoGenomics shares in Q1 2023, an estimated $112K.
  • Alpine Global Management first reported a position in NeoGenomics in Q1 2021 and held it in 2 quarters.
  • Alpine Global Management's NeoGenomics position peaked at $261K in Q1 2021.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.